ENBIOSIS has brought an innovative perspective to the health field by using a personalized recommendation system based on artificial intelligence technology. It is the first and only company that uses artificial intelligence in the analysis of health parameters and conducts R&D studies in the field of microbiome.

Using advanced artificial intelligence models and extensive database, ENBIOSIS analyzes trillions of bacteria in the intestine and scores health parameters individually for each person. ENBIOSIS has presented its customers with the first and only personalized prebiotic products in the world. The company’s solid team of scientists with broad international experience and extensive publication records continues its R&D activities.

Parameters assessed by Artificial Intelligence Technology:

  • Microbiome Age

  • Microbiome Diversity
  • Disease Predispositions

  • Probiotic Microorganisms

  • Intestinal Motility
  • Autoimmunity Index

  • Sleep Quality

  • Damage from Artificial Sweeteners

  • Antibiotic Damage
  • Protein Metabolism
  • Carbohydrate Metabolism
  • Fat Metabolism

  • Body Mass Index

  • Scoring of 215 Nutrients
  • Personalized Prebiotics